Experimental immunoprevention of type I diabetes mellitus (Q37437799)

20 August 2017

1 reference

title

Experimental immunoprevention of type I diabetes mellitus (English)

1 reference

20 August 2017

0 references

Boitard C

1

1 reference

20 August 2017

Timsit J

series ordinal

2

1 reference

20 August 2017

Sempé P

series ordinal

3

1 reference

20 August 2017

Bach JF

series ordinal

4

1 reference

20 August 2017

1 March 1991

1 reference

Diabetes/metabolism reviews

20 August 2017

1 reference

20 August 2017

7

1 reference

20 August 2017

1

1 reference

20 August 2017

15-33

1 reference

The diabetic syndrome of the 'BB' Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man.

20 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Genetic susceptibility to the development of spontaneous insulin-dependent diabetes mellitus in the rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Cyclosporin prevents diabetes in BB Wistar rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Cyclosporine: action, pharmacokinetics, and effect in the BB rat model

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Effect of cyclosporin on pancreatic events and development of diabetes in BB/Edinburgh rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Mechanisms of cyclosporine protection against spontaneous diabetes mellitus in the BB/W or rat.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Immunological and metabolic concomitants of cyclosporin prevention of diabetes in BB rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Preventive effects of cyclosporin on diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Effect of cyclosporine on immunologically mediated diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Effect of FK 506 on Spontaneous Diabetes in BB Rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

The immunosuppressant FK-506 prevents progression of diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin-A, and antiserum to rat lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Effect of cyclosporine and aminophylline on streptozotocin-induced diabetes in rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Theophylline protects against diabetes in BB rats and potentiates cyclosporine protection

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Studies of streptozotocin-induced insulitis and diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) Mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Involvement of O2 radicals in 'autoimmune' diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Diabetes induced with multiple subdiabetogenic doses of streptozotocin: lack of protection by exogenous superoxide dismutase

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Effects of (-)15-deoxyspergualin on pancreatic islet B-cell function in vitro and on the development of diabetes after multiple low dose streptozotocin administration

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Total Lymphoid Irradiation Prevents Diabetes Mellitus in the Bio-Breeding/Worcester (BB/W) Rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Diabetes Susceptibility of BALB/cBOM Mice Treated with Streptozotocin: Inhibition by Lethal Irradiation and Restoration by Splenic Lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Administration of silica prevents diabetes in BB-rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of lymphocytic thyroiditis and insulitis in diabetes-prone BB rats by the depletion of macrophages

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Studies on autoimmunity for initiation of beta-cell destruction. VI. Macrophages essential for development of beta-cell-specific cytotoxic effectors and insulitis in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Studies on autoimmunity for initiation of beta-cell destruction. V. Decrease of macrophage-dependent T lymphocytes and natural killer cytotoxicity in silica-treated BB rats.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Suppressive Effect of Antibodies to Immune Response Gene Products on the Development of Low-Dose Streptozotocin-induced Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Modulation of low-dose streptozotocin-induced diabetes in mice by administration of antibodies to I-A, I-E and I-J determinants

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Complete protection from low-dose streptozotocin-induced diabetes in mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Spontaneous Diabetes Mellitus: Reversal and Prevention in the BB/W Rat with Antiserum to Rat Lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Effect of helper and/or cytotoxic T-lymphocyte depletion on low-dose streptozocin-induced diabetes in C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of recurrent autoimmune diabetes in BB rats by anti-asialo-GM1 antibody

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

The involvement of Ly 2+ T cells in beta cell destruction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of cyclophosphamide-induced diabetes by anti-V beta 8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

The specificity of rejection and the absence of susceptibility of pancreatic islet beta cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Immunostimulation circumvents diabetes in NOD/Lt mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Interleukin 2 activates BB/W diabetic rat lymphoid cells cytotoxic to islet cells.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes mellitus in BB rats by neonatal stimulation of beta cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Dietary protein: a trigger of insulin-dependent diabetes in the BB rat?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Fish oil-enriched diet and reduction of low-dose streptozocin-induced hyperglycemia. Inhibition of macrophage activation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Gangliosides in vivo reduce diabetes incidence in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of type I diabetes in NOD mice by adjuvant immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Transfusions of whole blood prevent spontaneous diabetes mellitus in the BB/W rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of spontaneous but not of adoptively transferred diabetes by injection of neonatal BB/hooded hybrid rats with splenocytes or concanavalin A blasts from diabetes-free strains

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Neonatal induction of allogeneic tolerance prevents T cell-mediated autoimmunity in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Adoptive immunotherapy of diabetes in autologous nonobese diabetic mice with lymphoid cells ex vivo exposed to cyclosporin plus interleukin 2

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Delay in onset of insulitis in NOD mice following a single injection of CD 4 and CD8 antibodies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Pancreatic islet-specific T-cell clones from nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

An explanation for the protective effect of the MHC class II I–E molecule in murine diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Prevention of diabetes in non-obese diabetic I-Ak transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Antigen presenting function of class II MHC expressing pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610070105

7 January 2021

Identifiers

DOI

10.1002/DMR.5610070105

0 references

1 reference